Finance

Lists
301602:SHE
Shantou Institu of Ultrsnc Instrn Co Ltd
CNÂ¥16.16
+0.94%
(+0.15) 1D
Sep 30, 3:04:22 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301602...
Open
CNÂ¥16.01
High
CNÂ¥16.29
Low
CNÂ¥16.01
Mkt. cap
6.92B
Avg. vol.
4.94M
Volume
2.39M
Dividend
0.93%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jun 24, 2026
P/E ratio
64.34
52-wk high
CNÂ¥25.64
52-wk low
CNÂ¥13.40
EPS
CNÂ¥0.25
Shares outstanding
428.33M
No. of employees
737
Open
CNÂ¥16.01
High
CNÂ¥16.29
Low
CNÂ¥16.01
Mkt. cap
6.92B
Avg. vol.
4.94M
Volume
2.39M
Dividend
0.93%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jun 24, 2026
P/E ratio
64.34
52-wk high
CNÂ¥25.64
52-wk low
CNÂ¥13.40
EPS
CNÂ¥0.25
Shares outstanding
428.33M
No. of employees
737
News stories
From web sources and news partners
Profile
Shantou Institute of Ultrasonic Instruments Co., Ltd is China's biggest manufacturing base of ultrasound with longest history. SIUI goes through a technology development of A-B-C-D-E. Each step has driven the industry progress in China. A: A mode ultrasound equipment. B:B mode ultrasound imaging equipment. C:Color Doppler. In 1997, SIUI manufactured its first color Doppler system Apogee 800.D:Real-time 3D/4D ultrasound. In 2008, SIUI developed the real-time 3D/4D technology, and released a series of real-time 3D/ 4D color Doppler systems. E: Elastography. SIUI develops and manufactures a variety of ultrasound imaging systems and accessories for both human and veterinary use, and NDT equipment including phased-array ultrasonic flaw detector, conventional flaw detector, thickness gauge, probes and accessories. The company is currently organized into three product category divisions: ultrasound imaging systems, medical X-Ray imaging products, and non-destructive testing instruments. SIUI has been certified by ISO9001 Certification, European CE Marking and the U.S. Food and Drug Administration. Wikipedia
About Shantou Institu of Ultrsnc Instrn Co Ltd
CEO-
Employees737
FoundedNov 15, 1982
Headquarters-
SectorMedical device
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
69.93M
151.90M
66.33M
82.68M
Cost of goods sold
20.10M
49.56M
20.19M
30.11M
Cost of revenue
20.10M
49.56M
20.19M
30.11M
Research and development expenses
14.30M
10.79M
10.32M
11.67M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20.23M
27.28M
21.73M
18.37M
Operating expense
26.42M
45.18M
32.21M
29.29M
Total operating expenses
46.52M
94.74M
52.40M
59.40M
Operating income
23.41M
57.17M
13.92M
23.28M
Other non operating income
-7.18M
7.11M
-10.06M
9.77M
EBT including unusual items
22.85M
69.99M
10.16M
21.23M
EBT excluding unusual items
26.59M
59.23M
10.08M
19.57M
Income tax expense
2.35M
10.01M
1.04M
3.25M
Effective tax rate
10.30%
14.30%
10.28%
15.30%
Other operating expenses
-8.09M
6.04M
167.40K
61.92K
Net income
20.50M
59.98M
9.11M
17.98M
Net profit margin
29.31%
39.48%
13.74%
21.75%
Earnings per share
-
-
-
-
Interest and investment income
7.79M
8.23M
6.22M
5.34M
Interest expense
-
-
-
-
Net interest expenses
7.79M
8.23M
6.22M
5.34M
Depreciation and amortization charges
-
-
-
-
EBITDA
26.00M
60.00M
16.76M
26.34M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps